Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sofonac 5mg/2.5mg modified-release tablets
0407020AFBEADAC
|
Sofonac | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 1 |
|
Sofonac 10mg/5mg modified-release tablets
0407020AFBEAAAA
|
Sofonac | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Sofonac 20mg/10mg modified-release tablets
0407020AFBEABAB
|
Sofonac | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Sofonac 40mg/20mg modified-release tablets
0407020AFBEACAD
|
Sofonac | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.